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1. Introduction 
Solitary pulmonary nodule (SPN) or "coin lesion" is a rounded lesion that does not exceed 3 
cm in diameter, completely surrounded by normal lung parenchyma without other 
concomitant anomalies (not associated with atelectasis or adenopathy), and often 
asymptomatic. Lesions bigger than 3 cm are more properly called masses and are often 
malignant [1,2]. 
SPNs can be found randomly in the course of imaging exams conducted at the level of the neck, 
upper limbs, chest, abdomen, and are described in approximately 0.9-2% of all chest X-rays [3]. 
Since the early 80's the advent of computed tomography (CT) has resulted in a large increase 
in the frequency of detection of SPN. In the clinical practice it is important to determine the 
radiological and pathological features of benign and malignant tumors for an accurate 
management [4-13]. 
According to the literature the overall prevalence of SPNs ranged between 8% and 51% [14,15]. 
The American College of Chest Physicians (ACCP) does not recommend the implementation 
of screening for lung cancer in the general population because the implementation of these 
tests is not so far proved able to achieve a reduction of mortality rates [16].  
Because the diagnosis and treatment of early stage lung cancer allows  more favourable 
results, a close monitoring for identified lesions is recommended [17]. 
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A SPN can be attributed to various causes. The first step in the clinical evaluation of these 
lesions is to define the benignity or malignancy. The most common benign etiologies include 
infectious granulomas and hamartomas, while the most frequent malignant etiologies 
include primary lung cancer and lung metastases [2].  
The clinical relevance of accurately subtyping lung cancers was initially challenged by the 
advent of novel therapeutic options (targeted therapies, such as erlotinib/gefitinib and 
bevacizumab, or third-generation chemotherapeutic agents, such as pemetrexed), which are 
effective in specific lung cancer subtypes, and needed for a more detailed histological 
definition of non-small-cell lung cancer (NSCLC), separating at least squamous-cell 
carcinoma (SQC) from non-SQC. This event led pathologists to concentrate their efforts on 
the accurate diagnosis of small cell lung carcinoma (SCLC), because further subtyping of 
NSCLC was an optional and clinically unimportant diagnostic exercise. The generic 
diagnosis of NSCLC gained popularity originally for cytological samples and later  
for small biopsies. Currently, on cytological or small biopsy samples, most pathologists are 
able to correctly distinguish SCLC from NSCLC, and within the NSCLC group to identify 
well-differentiated or moderately differentiated SQC or adenocarcinoma (ADC). [18,19] 
However, a high percentage of cases continues to be simply diagnosed as NSCLC, especially 
when lacking clear-cut morphologic signs of differentiation. From a practical standpoint, the 
call back to histological categorization of NSCLC raises several types of questions. Although 
NSCLC subtyping may be relatively easy and feasible on surgical specimens, there are 
objective difficulties in examining small biopsies and cytology samples. These techniques 
often are the only ones for the final diagnosis of lung cancer, as most patients are not 
candidates for radical surgery. When dealing with these small samples, pathologists may be 
faced with a higher degree of uncertainty because of the frequent lung tumor heterogeneity 
and the higher prevalence of poorly differentiated NSCLC among clinically advanced and 
unresectable cases[18,19]. A useful tool to identify squamous or glandular differentiation 
and to characterize poorly differentiated NSCLC may be to incorporate ancillary techniques, 
such as immunohistochemistry. This approach seems the most promising one, although the 
accuracy, sensitivity, and specificity of the diverse immunohistochemical markers remain to 
be further defined. Thyroid transcription factor (TTF-1) and/or cytocheratin 7 (CK7) for 
ADC and p63 and high-molecular weight cytokeratins (HMWCKs) for SQC are the most 
specific and currently validated immunohistochemical markers that may be suitable for 
refining most diagnoses even when dealing with quantitatively limited material, such as 
cytological  samples or small-sized biopsies [20,21]. When the pathologist is not able to 
perform a precise histotype diagnosis, the high-resolution computed tomography (HRCT) 
may be proposed as further diagnostic approach for determining the lung histotype 
maligancies with single polmonary nodule presentation [21]. 
The aim of our study is to assess whether morphological characteristics of a SPN and 
ancillary signs allow to differentiate between the following lung malignancies: 
bronchioloalveolar carcinoma (BAC) classified in according to the new criteria, variants of 
ADC and SCLC. 
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2. Materials and methods 
2.1. Patients 
From January 2007 to June 2011 we retrospectively reviewed the HRCT examinations of 33 
patients (14 females and 19 males) with SPN presentation and histologic diagnosis of SCLC 
(n = 5), invasive lepidic ADCs (formerly diagnosed nommucinous BAC with > 5 mm 
invasion) (n=7), invasive mucinous ADCs (formerly diagnosed mucinous BAC)(n=2) and  
other variants invasive ADCs (acinar, papillary, solid predominant with mucin production, 
colloid and enteric variants) (n= 19). SQC, large cell carcinoma, adenosquamous carcinoma 
and sarcomatoid carcinoma cases were excluded. 
The mean age in the three type of SPNs (SCLC, BACs and ADCs ) were: 60 years ± 6 (SCLC), 
67,2 years ±8,2 (BACs) and  71, 3 years ± 8,5 (ADCs) respectively. 
2.2. Histological analysis 
The histological diagnosis was performed in accordance with the examination of lobectomy in 
all cases of ADCs and transbronchial biopsy in 5 SCLC. The classification of ADCs tumors was 
performed in accordance with the criteria of International Association for the Study of Lung 
Cancer/American Thoracic Society/European Respiratory Society International 
Mutlidisciplinary Classification of Lung Adenocarcinoma [22]. The following immunostaining 
analysis were performed in all cases of ADCs: TTF1, CK7, P63 and HMWCKs. The 
immunostaining of synaptophysin and CD56 was performed in all cases of SCLC.  
2.3. HRCT technique 
The examinations were performed with three different CT scanners: 16-slices CT (Light 
Speed Pro 16, GE, Milwaukee, USA), 16-slices CT (Toshiba Aquilion, Japan) and 64-slices CT 
(Philips Medical Systems, Best, the Netherlands) by direct volumetric acquisition with high 
spatial resolution CT (HRCT) in a single inspiratory breath with the patient in a supine 
position. The technical parameters expected to acquire volumetric reconstruction, are the 
following: collimation: 1.0-1.25mm, kV: 135, mA: 300, scan time: 0.7 sec / rotation, table 
speed of 17.85 mm / sec. High-spatial-frequency (bone) reconstruction algorithm was used. 
Using the axial images the multiplanar reconstructions (MPRs) with high diagnostic quality 
were obtained.  
2.4. Image analysis 
All HRCT images of each SNP were read in consensus by two experienced radiologists 
(M.S., A.R.) in chest CT with respect to morphology and ancillary signs. Size , 
margins/countours, calcifications, central necrosis or cavitation and air bronchogram were 
evaluated for the morphologic assessment [23]. Furthermore, in association with the 
morphological study the following ancillary signs were assessed:  pleural connecting striae 
and ground glass opacity (GGO).  
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The percentage of ancillary signs and the morphologic appearance were evaluated for the 
differential diagnosis. 
3. Results 
Lesion size ranging from 8 mm to 25 mm (mean 20 mm ±10,4 SD) for SCLC, 15 mm to 30 
mm ( mean 22,5 ± 5,7 SD) for BACs , 10 mm to 29mm ( mean 21,2 ± 5,9 SD) for ADCs. 
In the table are reported the data related to the morphologic features and to the ancillary 
signs with relatives percentages of the three histotype malignant nodules.  
Morfologic features: calcifications within the SPN were absent in all case of SCLC and BACs 
and found in 1/19 (5,2%) cases of ADCs variants; cavitation was observed in 1/5 (20%) cases 
of SCLC; margins/countours (irregular or spiculated, multilobulated, frayed) were revealed 
in SCLC, BACs and variants of ADC in 4/5 (80%) 9/9 (100%) 15/19 (79%) and air 
bronchogram was revealed in SCLC, BACs and variants of ADC in 2/5 (40%) 5/9 (60%) 8/19 
(42%) respectively. 
Ancillary signs: air bronchogram and pleural connecting striae were found in SCLC, BACs 
and variants of ADC in 2/5 (40%), 5/9 (60%), 8/19 (42%) and 3/5 (80%), 9/9 (100%) 17/19 (89%) 
respectively. 
The representative HRTC features for the three type of SPNs for SCLC, BACs and variants 
of ADC are reported in figures 1,2, figures 3-5 and figures 6-9 respectively. 
 
Figure 1. Small cell lung carcinoma in a 59 year-old man. HRCT shows spiculated and lobulated nodule 
with cavitations in the upper left lobe.  
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Figure 2. Small cell lung carcinoma in a 69 year-old man. 
HRCT shows spiculated nodule with pleural connecting striae in the ventral segment of the upper right lobe.  
 
HRCT features  
SCLC (size ranging 
from 8 mm to 25 mm 
(mean 20 mm ±10,4 SD)
(n=5) 
BAC (size ranging , 15 
mm to 30 mm 
(mean 22,5 ± 5,7 SD) 
(n=9) 
ADCs size ranging 10 
mm to 29mm 
(mean 21,2 ± 5,9 SD) 
(n=19) 
Calcifications  0/5 (0%) 0/9 (0%) 1/19 (5,2%) 
Cavitations  1/5 (20%) 0/9 (0%) 0/19 (0%) 
Margins (irregular or 
spiculated, 
multilobulated) 
4/5 (80%) 9/9 (100%) 15/19 (79%) 
Air bronchogram 2/5 (40%) 5/9 (60%) 8/19 (42%) 
Pleural connecting 
striae 
3/5 (80%) 9/9 (100%) 17/19 (89%) 
Ground-glass opacity 1/5 (20%) 9/10 (90%)* 5/19 (26,3%) 
*In  1 case of    invasive mucinous  adenocarcinoma  (formerly diagnosed mucinous bronchiolo-alveolar carcinomas) 
the  GGO appearance was not revealed. 
Table 1. HRCT morphologic and ancillary of 5 small cell lung carcinomas (SLCL), 7 invasive lepidic 
adenocarcinomas (formely diagnosed bronchiolo-alveolar carcinomas pattern, with > 5 mm invasion),  2 
invasive mucinous adenocarcinomas (formerly diagnosed mucinous bronchiolo-alveolar carcinomas)  
and 19 other variants invasive ADCs (acinar, papillary, solid predominant with mucin production, 
colloid and enteric variants). 
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Figure 3. Invasive mucinous adenocarcinoma (formerly diagnosed mucinous bronchiolo-alveolar 
carcinoma) in a 74 year-old female.  
HRCT shows spiculated nodule with pleural connecting striae in the dorsal segment of the left upper 
lobe.  
 
Figure 4. Invasive lepidic  adenocarcinoma  (formely diagnosed bronchiolo-alveolar carcinoma pattern, 
with > 5 mm   invasion) in a 75 year-old female. HRCT shows nodule with irregular contours and GGO 
in the ventral segment of the left upper lobe .  
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Figure 5. Invasive lepidic  adenocarcinoma (formely diagnosed bronchiolo-alveolar carcinoma pattern, 
with > 5 mm invasion) in a 75 year-old female. HRCT shows lobulated nodule with air bronchogram 
and GGO in the left lower lobe.  
 
Figure 6. Invasive variant enteric adenocarcinoma in a 76 year-old man. HRCT shows spiculated 
nodule with pleural connecting irregular striae in the dorsal upper right lobe.  
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Figure 7. Invasive variant enteric adenocarcinoma in a 79 year-old man.  
HRCT shows spiculated nodule with pleural connecting striae and GGO in the ventral upper righ lobe.  
 
Figure 8. Invasive variant colloid adenocarcinoma in a 64 year-old man. 
HRCT shows lobulated spiculated nodule with pleural connecting striae and GGO in the left lower lobe.  
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Figure 9. Invasive variant enteric high grade-fetal adenocarcinoma in a 64 year-old man. 
HRCT shows spiculated nodule with pleural connecting striae and GGO in the dorsal upper right lobe. 
4. Discussion 
Adenocarcinoma is the most common histologic subtype of lung cancer in most countries, 
accounting for almost half of all lung cancers [24]. A widely divergent clinical, radiologic, 
molecular, and pathologic spectrum exists within lung adenocarcinoma. As a result, 
confusion exists, and studies are difficult to compare. Despite remarkable advances in 
understanding of this tumor in the past decade, remains a need for universally accepted 
criteria for adenocarcinoma subtypes, in particular tumors formerly classified as BAC 
[18,19]. 
As the SPN may be the expression of multiple pathologic entities, the incidental finding of 
SPN by CT raises the issue of differential diagnosis between benign and malignant nodules. 
Moreover the importance of differential diagnosis between malignant histotypes can affect 
the prognosis and management of these patients. 
A number of terms have been used to describe lung ADC by CT imaging. In particular, for 
tumors that present as small nodules, the terms used have reflected the various ground 
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glass (nonsolid), solid, or part-solid appearances that can occur. Largely based on the 
Fleischner Society glossary of terms [21] and the recently suggested guidelines by Godoy 
and Naidich [25] for subsolid nodules, we propose the following definitions: (1) a pure 
ground-glass nodule (GGN) (synonym: nonsolid nodule) as a focal area of increased lung 
attenuation within which the margins of any normal structures, e.g., vessels, remain 
outlined, (2) a solid nodule as a focal area of increased attenuation of such density that 
any normal structures, e.g., vessels, are completely obscured, and (3) part solid nodule 
(synonym: semisolid nodule) as a focal nodular opacity containing both solid and ground-
glass components [21,25]. The Fleischner Society glossary of terms for thoracic imaging 
defines a nodule on a CT scan as “a rounded or irregular opacity, well or poorly defined, 
measuring up to 3 cm in greatest diameter” in any plane [21].  If the opacity is greater 
than 3 cm, it is referred to as a mass [21]. The 3 cm cut-off is in keeping with our concept 
of the maximum accepted size for the pathologic diagnosis of AIS and MIA. The term 
subsolid nodule has also entered common radiologic usage, referring to both part-solid 
nodules and a pure GGN [25]. Optimal evaluation of subsolid nodules requires thin-
section CT scans (<3 mm thickness) to assess the solid versus ground-glass components 
[20,21]. 
The aim of our study is to assess the morphologic and ancillary HRCT features of the 
histotypes of malignant SPNs considering that often histological and/or cytological material 
may be unsatisfactory and immunoistochemical techniques may be not performed.  
In our study the calcifications within the SPN were absent in all cases of SCLC and BACs 
and found in one case of ADCs.  
The margins were irregular or spiculated, multilobulated in 4/5 (80%) of SCLC, in 9/9 (100%) 
of cases previously diagnosed as BACs, and in 15/19 (79%) of other variants of ADCs.  
The opacity-like bullous, a sign of the presence of air bronchogram, does not help us in 
making any differential diagnosis, being present in 40% (2/5) of SCLC in 42% (8/19) of 
variants of ADCs and in 60% (5/9) of formerly diagnosed BACs. The occurrence of 
cavitations, expression of the speed of growth of the tumor cell and indicative of the 
presence of necrosis [26,27], was detected only in one aggressive forms of SCLC (20%). In all 
cases of all variants of ADCs and in cases previously diagnosed as BACs the cavitations 
were absent.  
The SPN may be connected to the pleura by striae or streaks defined as linear density that 
extends to the pleura and were the result of a fibrosis in the pulmonary peripheral lung. The 
striae connecting pleura or pleural effusion tags are found with high frequency in the three 
tumor subtypes, ranking as a sign that directs us to a differential diagnosis of malignancy 
without giving specific indications about the histotype tumor (80% SCLC, 89% variants of 
ADCs, 100% formerly diagnosed BACs). 
The ground glass perinodular opacity were areas of increased attenuation of hazy lung with 
preservation of bronchial and vascular margins [29] and intranodular air bronchogram  
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were the result of asymptomatic growth with the larger bronchi free of malignancies. The 
ground glass opacity (GGO) instead is significantly more present in the lesions slower 
growing and less invasive locoregional (26,3 % variants of ADCs and 90% formerly 
diagnosed BACs) than lesions infiltrative rapidly (only 20% of SCLC).   
In conclusion, ancillary signs (pleural striae and GGO) in association with air bronchogram 
are suggestive of diagnosis of the invasive lepidic ADCs (formerly diagnosed nommucinous 
BAC with > 5 mm invasion) and  can  be considered in the differential diagnosis of malignat 
SNPs histotypes ( SCLC and ADCs) 
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